Corticosterone reduces brain mitochondrial function and expression of mitofusin, BDNF in depression-like rodents regardless of exercise preconditioning

Psychoneuroendocrinology

Volumn 37, Issue 7, 2012, Pages 1057-1070

  Liu, Weina ^a   Zhou, Chenglin ^b  

^a TIANJIN UNIVERSITY OF SPORT   (China)

^b SHANGHAI UNIVERSITY OF SPORT   (China)

Author keywords

Chronic unpredictable mild stress; Corticosterone; Depression; Exercise; Mitochondrial

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; COPPER ZINC SUPEROXIDE DISMUTASE; CORTICOSTERONE; MANGANESE SUPEROXIDE DISMUTASE; MITOFUSIN 1; MITOFUSIN 2; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN MITOCHONDRION; COGNITION; CONTROLLED STUDY; DEPRESSION; ENERGY METABOLISM; ENERGY YIELD; EXERCISE; FORCED SWIMMING TEST; MALE; NERVE CELL PLASTICITY; NONHUMAN; OPEN FIELD TEST; OXIDATIVE STRESS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CORTICOSTERONE; DEPRESSION; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GENE EXPRESSION REGULATION; MALE; MEMBRANE PROTEINS; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; MOTOR ACTIVITY; PHYSICAL CONDITIONING, ANIMAL; RATS; RATS, WISTAR; RODENTIA; STRESS, PSYCHOLOGICAL;

EID: 84862822232     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2011.12.003     Document Type: Article

References (76)

1. Agbas A., Hui D., Wang X., Tek V., Zaidi A., Michaelis E.K. Activation of brain calcineurin (Cn) by Cu-Zn superoxide dismutase (SOD1) depends on direct SOD1-Cn protein interactions occurring in vitro and in vivo. Biochem. J. 2007, 405:51-59.
2. Appelhof B.C., Huyser J., Verweij M., Brouwer J.P., van Dyck R., Fliers E., et al. Glucocorticoids and relapse of major depression (dexamethasone/corticotropin-releasing hormone test in relation to relapse of major depression). Biol. Psychiatry 2006, 59:696-701.
3. Ben-Shachar D., Karry R. Neuroanatomical pattern of mitochondrial complex I pathology varies between schizophrenia, bipolar disorder and major depression. PLoS ONE 2008, 3:e3676.
4. Boveris A., Navarro A. Systemic and mitochondrial adaptive responses to moderate exercise in rodents. Free Radic. Biol. Med. 2008, 44:224-229.
5. Burnett B.B., Gardner A., Boles R.G. Mitochondrial inheritance in depression, dysmotility and migraine?. J. Affect. Disord. 2005, 88:109-116.
6. Carek P.J., Laibstain S.E., Carek S.M. Exercise for the treatment of depression and anxiety. Int. J. Psychiatry Med. 2011, 41:15-28.
7. Chaouloff F., Hemar A., Manzoni O. Local facilitation of hippocampal metabotropic glutamate receptor-dependent long-term depression by corticosterone and dexamethasone. Psychoneuroendocrinology 2008, 33:686-691.
8. Chen H., Chomyn A., Chan D.C. Disruption of fusion results in mitochondrial heterogeneity and dysfunction. J. Biol. Chem. 2005, 280:26185-26192.
9. Chen H., Vermulst M., Wang Y.E., Chomyn A., Prolla T.A., McCaffery J.M., et al. Mitochondrial fusion is required for mtDNA stability in skeletal muscle and tolerance of mtDNA mutations. Cell 2010, 141:280-289.
10. Chen K., Zhang Q., Wang J., Liu F., Mi M., Xu H., et al. Taurine protects transformed rat retinal ganglion cells from hypoxia-induced apoptosis by preventing mitochondrial dysfunction. Brain Res. 2009, 1279:131-138.
11. Clay H.B., Sillivan S., Konradi C. Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int. J. Dev. Neurosci. 2011, 29:311-324.
12. Coburn-Litvak P.S., Tata D.A., Gorby H.E., McCloskey D.P., Richardson G., Anderson B.J. Chronic corticosterone affects brain weight, and mitochondrial, but not glial volume fraction in hippocampal area CA3. Neuroscience 2004, 124:429-438.
13. D'Aquila P.S., Brain P., Willner P. Effects of chronic mild stress on performance in behavioural tests relevant to anxiety and depression. Physiol. Behav. 1994, 56:861-867.
14. David D.J., Samuels B.A., Rainer Q., Wang J.W., Marsteller D., Mendez I., et al. Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron 2009, 62:479-493.
15. Dekel N., Sonn J., Barbiro-Michaely E., Ornstein E., Mayevsky A. Effects of anesthesia on brain mitochondrial function, blood flow, ionic and electrical activity monitored in vivo. Adv. Exp. Med. Biol. 2009, 645:49-54.
16. Del B.R., Moggio M., Rango M., Bonato S., D'Angelo M.G., Ghezzi S., et al. Mutated mitofusin 2 presents with intrafamilial variability and brain mitochondrial dysfunction. Neurology 2008, 71:1959-1966.
17. Ding H., Jiang N., Liu H., Liu X., Liu D., Zhao F., et al. Response of mitochondrial fusion and fission protein gene expression to exercise in rat skeletal muscle. Biochim. Biophys. Acta 2010, 1800:250-256.
18. Du J., Wang Y., Hunter R., Wei Y., Blumenthal R., Falke C., et al. Dynamic regulation of mitochondrial function by glucocorticoids. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:3543-3548.
19. Eren I., Naziroglu M., Demirdas A., Celik O., Uguz A.C., Altunbasak A., et al. Venlafaxine modulates depression-induced oxidative stress in brain and medulla of rat. Neurochem. Res. 2007, 32:497-505.
20. Fattal O., Budur K., Vaughan A.J., Franco K. Review of the literature on major mental disorders in adult patients with mitochondrial diseases. Psychosomatics 2006, 47:1-7.
21. Fattal O., Link J., Quinn K., Cohen B.H., Franco K. Psychiatric comorbidity in 36 adults with mitochondrial cytopathies. CNS Spectr. 2007, 12:429-438.
22. Freitas T.P., Rezin G.T., Goncalves C.L., Jeremias G.C., Gomes L.M., Scaini G., et al. Evaluation of citrate synthase activity in brain of rats submitted to an animal model of mania induced by ouabain. Mol. Cell Biochem. 2010, 341:245-249.
23. Fuke S., Kubota-Sakashita M., Kasahara T., Shigeyoshi Y., Kato T. Regional variation in mitochondrial DNA copy number in mouse brain. Biochim. Biophys. Acta 2011, 1807:270-274.
24. Gadaleta M.N., Rainaldi G., Lezza A.M., Milella F., Fracasso F., Cantatore P. Mitochondrial DNA copy number and mitochondrial DNA deletion in adult and senescent rats. Mutat. Res. 1992, 275:181-193.
25. Galeffi F., Somjen G.G., Foster K.A., Turner D.A. Simultaneous monitoring of tissue PO2 and NADH fluorescence during synaptic stimulation and spreading depression reveals a transient dissociation between oxygen utilization and mitochondrial redox state in rat hippocampal slices. J. Cereb. Blood Flow Metab. 2011, 31:626-639.
26. Gardner A., Boles R.G. Symptoms of somatization as a rapid screening tool for mitochondrial dysfunction in depression. Biopsychosoc. Med. 2008, 2:7.
27. Gardner A., Boles R.G. Mitochondrial energy depletion in depression with somatization. Psychother. Psychosom. 2008, 77:127-129.
28. Gardner A., Johansson A., Wibom R., Nennesmo I., von Dobeln U., Hagenfeldt L., et al. Alterations of mitochondrial function and correlations with personality traits in selected major depressive disorder patients. J. Affect. Disord. 2003, 76:55-68.
29. Gomez-Pinilla F., Vaynman S., Ying Z. Brain-derived neurotrophic factor functions as a metabotrophin to mediate the effects of exercise on cognition. Eur. J. Neurosci. 2008, 28:2278-2287.
30. Gong Y., Chai Y., Ding J.H., Sun X.L., Hu G. Chronic mild stress damages mitochondrial ultrastructure and function in mouse brain. Neurosci. Lett. 2011, 488:76-80.
31. Holley A.K., Dhar S.K., St C.D. Manganese superoxide dismutase versus p53: the mitochondrial center. Ann. N.Y. Acad. Sci. 2010, 1201:72-78.
32. Horstmann S., Binder E.B. Glucocorticoids as predictors of treatment response in depression. Harv. Rev. Psychiatry 2011, 19:125-143.
33. Iijima M., Ito A., Kurosu S., Chaki S. Pharmacological characterization of repeated corticosterone injection-induced depression model in rats. Brain Res. 2010, 1359:75-80.
34. Jacobsen J.P., Mork A. Chronic corticosterone decreases brain-derived neurotrophic factor (BDNF) mRNA and protein in the hippocampus, but not in the frontal cortex, of the rat. Brain Res. 2006, 1110:221-225.
35. Katyare S.S., Balasubramanian S., Parmar D.V. Effect of corticosterone treatment on mitochondrial oxidative energy metabolism in developing rat brain. Exp. Neurol. 2003, 183:241-248.
36. Knaepen K., Goekint M., Heyman E.M., Meeusen R. Neuroplasticity - exercise-induced response of peripheral brain-derived neurotrophic factor: a systematic review of experimental studies in human subjects. Sports Med. 2010, 40:765-801.
37. Koene S., Kozicz T.L., Rodenburg R.J., Verhaak C.M., de Vries M.C., Wortmann S., et al. Major depression in adolescent children consecutively diagnosed with mitochondrial disorder. J. Affect. Disord. 2009, 114:327-332.
38. Kompagne H., Bardos G., Szenasi G., Gacsalyi I., Harsing L.G., Levay G. Chronic mild stress generates clear depressive but ambiguous anxiety-like behaviour in rats. Behav. Brain Res. 2008, 193:311-314.
39. Kudin A.P., Bimpong-Buta N.Y., Vielhaber S., Elger C.E., Kunz W.S. Characterization of superoxide-producing sites in isolated brain mitochondria. J. Biol. Chem. 2004, 279:4127-4135.
40. Lee B., Shim I., Lee H.J., Yang Y., Hahm D.H. Effects of acupuncture on chronic corticosterone-induced depression-like behavior and expression of neuropeptide Y in the rats. Neurosci. Lett. 2009, 453:151-156.
41. Llorens-Martin M., Torres-Aleman I., Trejo J.L. Mechanisms mediating brain plasticity: IGF1 and adult hippocampal neurogenesis. Neuroscientist 2009, 15:134-148.
42. Long J., Liu C., Sun L., Gao H., Liu J. Neuronal mitochondrial toxicity of malondialdehyde: inhibitory effects on respiratory function and enzyme activities in rat brain mitochondria. Neurochem. Res. 2009, 34:786-794.
43. Lucca G., Comim C.M., Valvassori S.S., Reus G.Z., Vuolo F., Petronilho F., et al. Effects of chronic mild stress on the oxidative parameters in the rat brain. Neurochem. Int. 2009, 54:358-362.
44. Lucca G., Comim C.M., Valvassori S.S., Reus G.Z., Vuolo F., Petronilho F., et al. Increased oxidative stress in submitochondrial particles into the brain of rats submitted to the chronic mild stress paradigm. J. Psychiatr. Res. 2009, 43:864-869.
45. Maes M., Galecki P., Chang Y.S., Berk M. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:676-692.
46. Malakhova L., Bezlepkin V.G., Antipova V., Ushakova T., Fomenko L., Sirota N., et al. The increase in mitochondrial DNA copy number in the tissues of gamma-irradiated mice. Cell Mol. Biol. Lett. 2005, 10:721-732.
47. Mayevsky A., Rogatsky G.G. Mitochondrial function in vivo evaluated by NADH fluorescence: from animal models to human studies. Am. J. Physiol. Cell Physiol. 2007, 292:C615-C640.
48. McKercher C.M., Schmidt M.D., Sanderson K.A., Patton G.C., Dwyer T., Venn A.J. Physical activity and depression in young adults. Am. J. Prev. Med. 2009, 36:161-164.
49. Murray F., Smith D.W., Hutson P.H. Chronic low dose corticosterone exposure decreased hippocampal cell proliferation, volume and induced anxiety and depression like behaviours in mice. Eur. J. Pharmacol. 2008, 583:115-127.
50. Navarro A., Gomez C., Lopez-Cepero J.M., Boveris A. Beneficial effects of moderate exercise on mice aging: survival, behavior, oxidative stress, and mitochondrial electron transfer. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004, 286:R505-R511.
51. Nie W., Zhang Z.Y., Zhou J.H. Correlation between mitochondrial membrane potential and neurotoxic effect of corticosterone on primary cultured hippocampal cells. Sheng Li Xue Bao 2001, 53:469-472.
52. Olivier J.D., Van Der Hart M.G., Van Swelm R.P., Dederen P.J., Homberg J.R., Cremers T., et al. A study in male and female 5-HT transporter knockout rats: an animal model for anxiety and depression disorders. Neuroscience 2008, 152:573-584.
53. Papp M., Willner P., Muscat R. An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress. Psychopharmacology (Berlin) 1991, 104:255-259.
54. Rezin G.T., Amboni G., Zugno A.I., Quevedo J., Streck E.L. Mitochondrial dysfunction and psychiatric disorders. Neurochem. Res. 2009, 34:1021-1029.
55. Rezin G.T., Cardoso M.R., Goncalves C.L., Scaini G., Fraga D.B., Riegel R.E., et al. Inhibition of mitochondrial respiratory chain in brain of rats subjected to an experimental model of depression. Neurochem. Int. 2008, 53:395-400.
56. Rezin G.T., Goncalves C.L., Daufenbach J.F., Fraga D.B., Santos P.M., Ferreira G.K., et al. Acute administration of ketamine reverses the inhibition of mitochondrial respiratory chain induced by chronic mild stress. Brain Res. Bull. 2009, 79:418-421.
57. Rollins B., Martin M.V., Sequeira P.A., Moon E.A., Morgan L.Z., Watson S.J., et al. Mitochondrial variants in schizophrenia, bipolar disorder, and major depressive disorder. PLoS ONE 2009, 4:e4913.
58. Salustri C., Squitti R., Zappasodi F., Ventriglia M., Bevacqua M.G., Fontana M., et al. Oxidative stress and brain glutamate-mediated excitability in depressed patients. J. Affect. Disord. 2010, 127:321-325.
59. Searle A., Calnan M., Lewis G., Campbell J., Taylor A., Turner K. Patients' views of physical activity as treatment for depression: a qualitative study. Br. J. Gen. Pract. 2011, 61:149-156.
60. Shiba T., Yamato M., Kudo W., Watanabe T., Utsumi H., Yamada K. In vivo imaging of mitochondrial function in methamphetamine-treated rats. Neuroimage 2011, 57:866-872.
61. Sionov R.V., Kfir S., Zafrir E., Cohen O., Zilberman Y., Yefenof E. Glucocorticoid-induced apoptosis revisited: a novel role for glucocorticoid receptor translocation to the mitochondria. Cell Cycle 2006, 5:1017-1026.
62. Stedenfeld K.A., Clinton S.M., Kerman I.A., Akil H., Watson S.J., Sved A.F. Novelty-seeking behavior predicts vulnerability in a rodent model of depression. Physiol. Behav. 2011, 103:210-216.
63. Sun L., Shen W., Liu Z., Guan S., Liu J., Ding S. Endurance exercise causes mitochondrial and oxidative stress in rat liver: effects of a combination of mitochondrial targeting nutrients. Life Sci. 2010, 86:39-44.
64. Toups M.S., Greer T.L., Kurian B.T., Grannemann B.D., Carmody T.J., Huebinger R., et al. Effects of serum brain derived neurotrophic factor on exercise augmentation treatment of depression. J. Psychiatr. Res. 2011.
65. Tsai S.J. Brain-derived neurotrophic factor: a bridge between major depression and Alzheimer's disease?. Med. Hypotheses 2003, 61:110-113.
66. Ulloa J.L., Castaneda P., Berrios C., Diaz-Veliz G., Mora S., Bravo J.A., et al. Comparison of the antidepressant sertraline on differential depression-like behaviors elicited by restraint stress and repeated corticosterone administration. Pharmacol. Biochem. Behav. 2010, 97:213-221.
67. Vergun O., Votyakova T.V., Reynolds I.J. Spontaneous changes in mitochondrial membrane potential in single isolated brain mitochondria. Biophys. J. 2003, 85:3358-3366.
68. Wang X., Su B., Lee H.G., Li X., Perry G., Smith M.A., et al. Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. J. Neurosci. 2009, 29:9090-9103.
69. Wilhelm F., Hirrlinger J. The NAD(+)/NADH redox state in astrocytes: independent control of the NAD(+) and NADH content. J. Neurosci. Res. 2011.
70. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology (Berlin) 1997, 134:319-329.
71. Yang D., Li Q., Fang L., Cheng K., Zhang R., Zheng P., et al. Reduced neurogenesis and pre-synaptic dysfunction in the olfactory bulb of a rat model of depression. Neuroscience 2011.
72. Yu S., Holsboer F., Almeida O.F. Neuronal actions of glucocorticoids: focus on depression. J. Steroid Biochem. Mol. Biol. 2008, 108:300-309.
73. Zeevalk G.D., Manzino L., Sonsalla P.K., Bernard L.P. Characterization of intracellular elevation of glutathione (GSH) with glutathione monoethyl ester and GSH in brain and neuronal cultures: relevance to Parkinson's disease. Exp. Neurol. 2007, 203:512-520.
74. Zheng H., Liu Y., Li W., Yang B., Chen D., Wang X., et al. Beneficial effects of exercise and its molecular mechanisms on depression in rats. Behav. Brain Res. 2006, 168:47-55.
75. Zou Y.F., Wang Y., Liu P., Feng X.L., Wang B.Y., Zang T.H., et al. Association of brain-derived neurotrophic factor genetic Val66Met polymorphism with severity of depression, efficacy of fluoxetine and its side effects in Chinese major depressive patients. Neuropsychobiology 2010, 61:71-78.
76. Zunszain P.A., Anacker C., Cattaneo A., Carvalho L.A., Pariante C.M. Glucocorticoids, cytokines and brain abnormalities in depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:722-729.